HNB
RIGL icon

Huntington National Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

Huntington National Bank’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 4085
2025
Q4 		$1 Sell
1
-100
-99% -$3.77K ﹤0.01% 3991
2025
Q3 		$2.83K Sell
101
-74
-42% -$2.21K ﹤0.01% 2129
2025
Q2 		$3.26K Buy
175
+101
+136% +$1.92K ﹤0.01% 2108
2025
Q1 		$1.31K Buy
74
+73
+7,300% +$1.48K ﹤0.01% 2323
2024
Q4 		$1 Hold
1
– – ﹤0.01% 4034
2024
Q3 		$1 Sell
1
-77
-99% -$905 ﹤0.01% 4027
2024
Q2 		$632 Buy
78
+24
+44% +$251 ﹤0.01% 2383
2024
Q1 		$799 Buy
+54
New +$728 ﹤0.01% 2314
2023
Q4 		– Hold
0
– – – 3743

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Huntington National Bank's RIGL Position: Q1 2026 in Review

Huntington National Bank held its Rigel Pharmaceuticals (RIGL) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

Huntington National Bank first reported a position in RIGL in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.26K in Q2 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Huntington National Bank held 1 share of Rigel Pharmaceuticals worth $1 as of Q1 2026.
  • Huntington National Bank left its Rigel Pharmaceuticals share count unchanged in Q1 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4085 holding.
  • Huntington National Bank first reported a position in Rigel Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Huntington National Bank's Rigel Pharmaceuticals position peaked at $3.26K in Q2 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.